Sökresultat - "GLIOBLASTOMA multiforme"

N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11.

Cho, Hye Joung^1,2 (AUTHOR) hjcho3633@yuhs.ac, Yoo, Jihwan^3,4 (AUTHOR) jhy8486@yuhs.ac, Choi, Ran Joo^1,2 (AUTHOR) rjc98@yuhs.ac, Lee, Jae-Seon⁵ (AUTHOR) ljs891109@gmail.com, Kim, Ryong Nam^1,2 (AUTHOR) ryongnamkim@yuhs.ac, Park, Junseong^1,6 (AUTHOR) j.p@catholic.ac.kr, Moon, Ju Hyung¹ (AUTHOR) mjjr80@yuhs.ac, Kim, Eui Hyun¹ (AUTHOR) euihyunkim@yuhs.ac, Teo, Wan-Yee^7,8 (AUTHOR) teo.wan.yee@duke-nus.edu.sg, Chang, Jong Hee¹ (AUTHOR) changjh@yuhs.ac, Kim, Soo-Youl⁵ (AUTHOR) kimsooyoul@gmail.com, Kang, Seok-Gu^1,2,4,9 (AUTHOR) seokgu9@gmail.com

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.

Bell, Jonathan B.¹ (AUTHOR), Sheriff, Sulaiman² (AUTHOR), Goryawala, Mohammed Z.² (AUTHOR), Cullison, Kaylie¹ (AUTHOR), Azzam, Gregory A.¹ (AUTHOR), Meshman, Jessica¹ (AUTHOR), Abramowitz, Matthew C.¹ (AUTHOR), Ivan, Michael E.³ (AUTHOR), de la Fuente, Macarena I.⁴ (AUTHOR), Mellon, Eric A.¹ (AUTHOR) eric.mellon@med.miami.edu

Survivin Interference and SurVaxM as an Adjunct Therapy for Glioblastoma Multiforme.

Elliott, Willie James¹ (AUTHOR), Gurramkonda, Nandini^1,2 (AUTHOR), Guda, Maheedhara R.^1,3 (AUTHOR), Tsung, Andrew J.^1,2,3,4 (AUTHOR), Velpula, Kiran K.^1,2,4 (AUTHOR) velpula@uic.edu

Taurochenodeoxycholic acid suppresses the progression of glioblastoma via HMGCS1/HMGCR/GPX4 signaling pathway in vitro and in vivo.

Xue, Xiumin¹ (AUTHOR), He, Ziwan¹ (AUTHOR), Liu, Furui¹ (AUTHOR), Wang, Qian¹ (AUTHOR), Chen, Zhichao¹ (AUTHOR), Lin, Lin¹ (AUTHOR), Chen, Danni¹ (AUTHOR), Yuan, Yinfeng¹ (AUTHOR), Huang, Zhihui¹ (AUTHOR) huang0069@hznu.edu.cn, Wang, Yongjie¹ (AUTHOR) wangyongjie@hznu.edu.cn

Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies.

Rawojć, Kamila¹ (AUTHOR) kamila.rawojc@dworska.pl, Ahmed, Mansoor M.² (AUTHOR), Mukhtiar, Ayesha³ (AUTHOR), Łukowiak, Magdalena⁴ (AUTHOR), Kisielewicz, Kamil¹ (AUTHOR)

Vortioxetine exhibits anti-glioblastoma activity via the PI3K-Akt signaling pathway.

Huan-qi Zhang^1,2, Dao-ming Zhang^1,2, Zhi-zhen Huang^1,3, Jing Cheng^1,3, Chong Zhang³, Neng-ming Lin², Yangling Li² liyangling1215@163.com

Glioblastoma in NF1: A Unique Entity—A Literature Review Focusing on Surgical Implication and Our Experience.

Garbin, Elisa¹ (AUTHOR) luca.denaro@unipd.it, Nicolè, Lorenzo² (AUTHOR), Magrini, Salima³ (AUTHOR), Ceccaroni, Yuri³ (AUTHOR), Denaro, Luca¹ (AUTHOR), Basaldella, Luca³ (AUTHOR), Rossetto, Marta³ (AUTHOR) marta.rossetto@aulss3.veneto.it

Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study.

Mason, Warren P.¹ (AUTHOR) warren.mason@uhn.ca, Harrison, Rebecca A.² (AUTHOR), Lapointe, Sarah^3,4 (AUTHOR), Lim-Fat, Mary Jane^4,5 (AUTHOR), MacNeil, Mary V.^5,6,7 (AUTHOR), Mathieu, David^6,8 (AUTHOR), Perry, James R.^7,9,10 (AUTHOR), Pitz, Marshall W.^8,11,12 (AUTHOR), Roberge, David^9,13,14 (AUTHOR), Tsang, Derek S.^10,15 (AUTHOR), Tsien, Christina^11,16 (AUTHOR), van Landeghem, Frank K. H.^12,17 (AUTHOR), Zadeh, Gelareh^13,18,19 (AUTHOR), Easaw, Jacob^14,20 (AUTHOR)

How Can We Engage Oncology Care Providers and Glioblastoma Patients in Conversations About Physical Activity: A Qualitative Descriptive Study Using the Theoretical Domains Framework.

Langley, Jodi E.^1,2 (AUTHOR) jodi.langley@dal.ca, Warner, Grace^1,2 (AUTHOR), Cassidy, Christine^1,3 (AUTHOR), Urquhart, Robin^2,3,4 (AUTHOR), MacNeil, Mary^3,4 (AUTHOR), Keats, Melanie R.^1,2,4 (AUTHOR)

Molecular mechanisms and therapeutic targets in glioblastoma multiforme: network and single-cell analyses.

Chen, Xiangyu¹ (AUTHOR), Zhong, Xiao¹ (AUTHOR), Zhang, Feifei² (AUTHOR), Zhou, Xiaomei³ (AUTHOR), Yue, Xiaofeng⁴ (AUTHOR) 652282@hospital.cqmu.edu.cn, Li, Xueru¹ (AUTHOR) 2020130299@stu.cqmu.edu.cn

A Benzodiazepine-Derived Molecule That Interferes with the Bio-Mechanical Properties of Glioblastoma-Astrocytoma Cells Altering Their Proliferation and Migration.

Ragazzini, Gregorio^1,2 (AUTHOR), Mescola, Andrea^2,3 (AUTHOR) alessia.gallerani@unimore.it, Tassinari, Riccardo^2,3 (AUTHOR), Gallerani, Alessia^1,4 (AUTHOR), Zannini, Chiara^2,5 (AUTHOR), Di Rosa, Domenico^4,6 (AUTHOR), Cavallini, Claudia^2,7 (AUTHOR), Marcuzzi, Martina^5,8 (AUTHOR), Taglioli, Valentina^1,2 (AUTHOR), Bighi, Beatrice^1,2,3 (AUTHOR), Ettari, Roberta^3,6 (AUTHOR), Zappavigna, Vincenzo^4,7 (AUTHOR), Ventura, Carlo^2,5,8 (AUTHOR), Alessandrini, Andrea^1,3,6,8 (AUTHOR), Corsi, Lorenzo^7,8 (AUTHOR) lorenzo.corsi@unimore.it

Seco-Duocarmycin SA in Aggressive Glioblastoma Cell Lines.

Morcos, Ann^1,2 (AUTHOR), Jung, Yeonkyu^1,2 (AUTHOR), Fuller, Ryan N.³ (AUTHOR), Bertucci, Antonella^1,4 (AUTHOR), Nguyen, Amy⁵ (AUTHOR), Zhang, Quanqing^5,6 (AUTHOR), Emge, Tobias^1,2,7 (AUTHOR), Boyle, Kristopher E.^1,6 (AUTHOR), Wall, Nathan R.^1,2 (AUTHOR) nwall@llu.edu, Vazquez, Marcelo^1,3,7 (AUTHOR) marcelo.vazquez@cnl.ca

GOLPH3-mTOR Crosstalk and Glycosylation: A Molecular Driver of Cancer Progression.

Frappaolo, Anna¹ (AUTHOR), Zaccagnini, Gianluca¹ (AUTHOR), Giansanti, Maria Grazia¹ (AUTHOR) mariagrazia.giansanti@cnr.it

Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy.

Dana, Nasim¹ (AUTHOR), Dabiri, Arezou¹ (AUTHOR), Najafi, Majed Bahri¹ (AUTHOR), Rahimi, Azadeh¹ (AUTHOR), Ishaghi, Sayed Mohammad Matin² (AUTHOR), Shariati, Laleh^3,4 (AUTHOR), Shao, Minmin⁵ (AUTHOR), Borzacchiello, Assunta⁶ (AUTHOR), Rahimmanesh, Ilnaz¹ (AUTHOR) ilnazrahimmanesh@gmail.com, Makvandi, Pooyan^7,8,9 (AUTHOR) pooyan.makvandi@wmu.edu.cn

InfoScan: A New Transcript Identification Tool Based on scRNA-Seq and Its Application in Glioblastoma.

Mei, Shiqiang¹ (AUTHOR), Huang, Jinjin¹ (AUTHOR), Zhang, Zhen¹ (AUTHOR), Lei, Haotian¹ (AUTHOR), Huang, Qiaojuan¹ (AUTHOR), Qu, Lianghu¹ (AUTHOR), Zheng, Lingling (AUTHOR) zhengll33@mail.sysu.edu.cn

Malignant Cells Beyond the Tumor Core: The Non‐Negligible Factor to Overcome the Refractory of Glioblastoma.

Zhou, Yuyang¹ (AUTHOR), He, Qilin¹ (AUTHOR), Huang, Guanglong¹ (AUTHOR), Ouyang, Pei¹ (AUTHOR), Wang, Hai¹ (AUTHOR), Deng, Jiapeng¹ (AUTHOR), Chen, Pengyu¹ (AUTHOR), Liang, Xuan¹ (AUTHOR), Hong, Zhisheng¹ (AUTHOR), Zhang, Xian¹ (AUTHOR) zhangxiannfyy@163.com, Qi, Songtao¹ (AUTHOR) qisongtaonanfang@163.com, Li, Yaomin¹ (AUTHOR) lym712@163.com

Cognitive Decline in Glioblastoma (GB) Patients with Different Treatment Modalities and Insights on Untreated Cases.

Ghadimi, Keyvan¹ (AUTHOR) keyvan.ghadimi@einsteinmed.edu, Abbas, Imane (AUTHOR), Karandish, Alireza¹ (AUTHOR), Crisman, Celina¹ (AUTHOR), Eskandar, Emad N.¹ (AUTHOR), Kobets, Andrew J.¹ (AUTHOR)

Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management.

Zarif Attalla, Kristina¹ (AUTHOR), Hassan, Doaa H.^1,2 (AUTHOR), Teaima, Mahmoud H.^2,3 (AUTHOR), Yousry, Carol^2,3,4 (AUTHOR), El-Nabarawi, Mohamed A.^2,5 (AUTHOR), Said, Mohamed A.^1,4 (AUTHOR), Elhabal, Sammar Fathy^2,5 (AUTHOR)

A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme.

Alkayyal, Almohanad A.¹ (AUTHOR) aalkayyal@ut.edu.sa, Mahmoud, Ahmad Bakur^2,3 (AUTHOR) abamahmoud@taibahu.edu.sa

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies.

Pouyan, Ashkan¹ (AUTHOR), Ghorbanlo, Masoud² (AUTHOR), Eslami, Masoud³ (AUTHOR), Jahanshahi, Majid⁴ (AUTHOR), Ziaei, Ehsan⁵ (AUTHOR), Salami, Ali⁶ (AUTHOR), Mokhtari, Khatere⁷ (AUTHOR), Shahpasand, Koorosh^8,9 (AUTHOR), Farahani, Najma⁸ (AUTHOR), Meybodi, Tohid Emami^10,11 (AUTHOR) tohid.emami@sbmu.ac.ir, Entezari, Maliheh⁸ (AUTHOR), Taheriazam, Afshin^8,12 (AUTHOR) a.taheriazam@iautmu.ac.ir, Hushmandi, Kiavash^8,13 (AUTHOR) houshmandi.kia7@ut.ac.ir, Hashemi, Mehrdad⁸ (AUTHOR) mhashemi@iautmu.ac.ir